A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model
表达融合前稳定型 SARS-CoV-2 刺突蛋白的麻疹载体候选疫苗已进入 I/II 期临床试验:在临床前小鼠模型中进行候选疫苗筛选
期刊:Journal of Virology
影响因子:4
doi:10.1128/jvi.01693-23
Jérémy Brunet #, Zaineb Choucha #, Marion Gransagne #, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh